Reprocessing: the C2DS takes it to the next level!

operating room

An ordinance issued in April 2022 prohibited the reprocessing of medical devices, even though it preserves all their original qualities. The C2DS has called on 45 members of parliament to authorize reprocessing in France.

Press release

In the United States and Germany, reprocessing is permitted, with numerous advantages and a high level of safety. According to studies carried out in Europe, the proven benefits of reprocessing are as follows:

  • A reduction of more than 50% in greenhouse gas emissions and more than 28% in the withdrawal of abiotic resources
  • No increased risk for the patient and significant cost savings

In addition, remarketing reprocessed single-use DM would also allow :

  • Reduce growing supply difficulties, a factor of disorganization and therefore of risk,
  • Avoid incinerating medical devices that may contain resources critical to France, such as platinum or gold,
  • Reduce the pressure of mining these same resources,
  • Increase the use of certain technologies currently limited by the very high cost of DM,
  • Set up short circuits and create local jobs, as is the case in Germany.
Share this article

Leave a comment

Your e-mail address will not be published. Required fields are marked with *.

This site uses Akismet to reduce spam. Find out more about how your feedback is processed.